推薦產品
抗體產品種類
secondary antibodies
用途
sufficient for 2,000 tests ELISA, Immunoblotting
sufficient for 200 tests Immunohistology
運輸包裝
wet ice
儲存溫度
2-8°C
目標翻譯後修改
unmodified
尋找類似的產品？ 前往 產品比較指南
一般說明
包含可与一抗联用的通用试剂，适用于免疫组化、ELISA和免疫印迹。
ExtrAvidin®是一种形式独特的亲和素，由Sigma独家供货，可将亲和素对生物素的高特异性和高亲和性与在生理条件下的低非特异性有机结合在一起。ExtrAvidin®过氧化物酶具有灵敏度高、本底水平低的特点。
ExtrAvidin®是一种形式独特的亲和素，由Sigma独家供货，可将亲和素对生物素的高特异性和高亲和性与在生理条件下的低非特异性有机结合在一起。ExtrAvidin®过氧化物酶具有灵敏度高、本底水平低的特点。
應用
Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunohistochemistry (1 paper)
Immunohistochemistry (1 paper)
特點和優勢
- 可用于免疫组化、ELISA和免疫印迹检测。
- 使用human IgG和IgM对亲和纯化的抗体进行吸附，可最大限度减少交叉反应。
- 生物素标记的抗体含有一段间隔肽链，可提高其与ExtrAvidin® 偶联物的亲和性。
成分
• 3 mL ExtrAvidin®-过氧化物酶
• 3 mL生物素标记的二抗
• 附带完整使用说明和实验方案
• 3 mL生物素标记的二抗
• 附带完整使用说明和实验方案
法律資訊
ExtrAvidin is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our 產品選擇工具.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Matheus L Medeiros et al.
Journal of inflammation research, 14, 6477-6489 (2021-12-10)
Methylglyoxal (MGO) is a highly reactive dicarbonyl species implicated in diabetic-associated diseases. Acute lung injury (ALI) symptoms and prognosis are worsened by diabetes and obesity. Here, we hypothesized that elevated MGO levels aggravate ALI, which can be prevented by metformin.
Akila L Oliveira et al.
Frontiers in physiology, 13, 860342-860342 (2022-04-15)
Methylglyoxal (MGO) is a highly reactive dicarbonyl compound implicated in diabetes-associated diseases. In vascular tissues, MGO induces the formation of advanced glycation end products (AGEs) that bounds its receptor RAGE, initiating the downstream tissue injury. Outside the cardiovascular system, MGO
Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.
Vladimirs Pilipenko et al.
Neuropharmacology, 144, 319-326 (2018-11-09)
Early manifestations of Alzheimer's disease (AD) include neuroinflammation, disrupted neurotransmission and cognitive deficits. Impairment of the GABAergic system is essentially involved in the pathogenesis of AD. Traditionally, agonists of GABAA receptors at doses above 1 mg/kg are known to possess memory
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務